Tired of the "No Bed Syndrome" crippling our healthcare system? Repherod is revolutionizing medical referrals with a cloud-based platform that seamlessly connects patients with the right care, at the right time.
Our secure, digital platform empowers medical practitioners to efficiently refer patients between facilities, seamlessly connecting ambulance services, eliminating wait times, and maximizing bed utilization.
We are working relentlessly to put an end to the "No Bed Syndrome", a Syndrome that has plagued the medical referral system for decades.
Currently, we have developed the minimum viable product (MVP) and Pilot testing is under way. The pilot testing is expected to take place at a teaching hospital and a district hospital in the Greater Accra Region.
We're poised to scale nationwide, optimizing healthcare delivery and improving patient outcomes. Join us as we revolutionize medical referrals and improve patient lives.
Invest in Repherod as we build a better medical referral system that span acrose the West African sub-regions.
Youtube: https://www.youtube.com/channel/UCG4dYT3BLJHr3zhZtMRHMLA
Website: www.repherod.com
Beta test product: .................coming soon
Company Details
- Employees
- 1
- Founded
- -
- Address
- Accra, Greater Accra, Gh
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- https://www.repherod.com/
- Keywords
- healthcare and Technology.
- HQ
- Accra, Greater Accra
Repherod Questions
Repherod's website is https://www.repherod.com/
Repherod's LinkedIn profile is https://gh.linkedin.com/company/repherod
Repherod has
1 employees.
View email and phone details for 1
employees at Repherod.
Repherod's industry is
Hospitals and Health Care
Repherod's top competitors are
Accad Healthcare,
Agki Medical Laboratory,
Husk Technologies,
Sage Medical Center,
Amat Clinic,
Nahge Clinic Ltd,
Curare,
Baiden-Ghartey Hospital,
Healthyam_za,
Central Dansoman Clinic.
Repherod's categories are Hospitals and Health Care
Repherod's founding year is 2023
